All the Drug Class Drugs
Centrally Acting Sympathomimetics. Lisdexamfetamine 10 mg/ml. Bottle, oral sol. 100 ml
ADHD: starting dosage in adults and ped. pts 6 years and older is 30 mg (equivalent to 3 ml) once/d in the morning. Dosage may be adj. in incr. of 10 mg (equivalent to 1 ml) or 20 mg (equivalent to 2 ml) at approx. weekly intervals up to max. dosage of 70 mg (equivalent to 7 ml) once/d.
Moderate to Severe BED in Adults: starting dosage in adults is 30 mg (equivalent to 3 ml) once /d to be titrated in incr. of 20 mg (equivalent to 2 ml) at approx. weekly intervals to achieve target dose of 50 to 70 mg (equivalent to 5 ml to 7 ml) once daily. The max. dosage is 70 mg/once daily (equivalent to 7 ml/once daily).
See prescribing info. for full details.
• Attention Deficit Hyperactivity Disorder (ADHD) in pts. ages 6 years and above.
• Mod. to Sev. Binge Eating Dis.(BED) for pts over 18 years.
C/I:Hypersens. Known hypersens. to amphetamine prod. Anaphylactic reactions, Stevens Johnson Syndrome, angioedema, and urticaria have been observed in post-marketing reports./Pts taking monoamine oxidase inhibit. (MAOIs), or within 14 days of stopping MAOIs (incl. MAOIs such as linezolid or intravenous methylene blue), because of an incr. risk of hypertensive crisis
Centrally Acting Sympathomimetics. Solriamfetol 75 mg, 150 mg. FC tabs 7,28,56 X 75/150 mg
Narcolepsy: recomm. starting dose is 75 mg 1/d, max dd is 150 mg
OSA: recomm. starting dose is 37.5 mg 1/d, max dd is 150 mg
To improve wakefulness and reduce excessive daytime sleepiness in adults with narcolepsy (with or w/ot cataplexy).
Also to improve wakefulness and reduce excessive daytime sleepiness (EDS) in adults with obstructive sleep apnoea (OSA) whose EDS has not been satisfactorily treated by primary OSA ther., such as CPAP.
C/I: Hypersens. /MI within the past year, unstable angina pectoris, uncontrolled HT serious cardiac arrhythmias and other serious heart problems/
Concom. use of MAOI or within 14 days after MAOI has been discontinued
Centrally Acting Sympathomimetics. Lisdexamfetamine (Dismesylate) 30, 50, 70 mg. CAPS: 28, 30,100×30, 50, 70mg. The recom. start. dose is 30 mg ×1/d in the morn. in pts. ages 6 and above. Dosage may be adjust. in increments of 20 mg at approx. wkly. intervals up to max. dose of 70 mg/d. Pts. may be maint. on their optim. dose.
Tmt. of ADHD in pts. ages 6 yrs. and above.
C/I: Known hypersens. to amphetamine, anaphylac. react., Stevens-Johnson Synd., angioed., urticaria.
Concur. admin. of MAOI’s or admin.of Lisdexamfetamine within 14 days of the last MAOI’s dose Hypertens. crisis can occur).
